Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    87,480.74
    -1,275.48 (-1.44%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Today's Research Reports on Trending Tickers: Teladoc Health and CV Sciences

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / September 24, 2018 / U.S. markets were mixed on Friday, with the Dow Jones managing to close at an all-time high despite a plunge in technology and internet stocks. Investors appear to be cautious as a potential trade war looms. The Dow Jones Industrial Average gained 0.32 percent to close at 26,743.50, while the S&P 500 Index declined 0.04 percent to close at 2,929.67. The Nasdaq Composite Index decreased 0.51 percent to close at 7,986.96. Trade tension between U.S. and China continues as President Donald Trump announced almost $500 billion tariffs on Chinese goods.

According to Peter Lazaroff, co-chief investment officer at Plancorp, “We don’t have a full-out trade war, and at this point, most people understand the impact of what’s happened so far won’t be too big on margins. And since earnings and revenue growth are as high as they’ve ever been, it’s perfectly fair for stocks to be at records.”

“However, given that valuations are pretty high, the prospect of our getting a pullback should be at the forefront of investors’ minds. That would just be part of a healthy, functioning market, however. Overall markets aren’t euphoric or complacent about the risks out there,” he added.

RDI Initiates Coverage on:

Teladoc Health, Inc.
https://rdinvesting.com/news/?ticker=TDOC

ADVERTISEMENT

CV Sciences, Inc.
https://rdinvesting.com/news/?ticker=CVSI

Teladoc Health's stock jumped 3.58% Friday, to close the day at $78.10. The stock recorded a trading volume of 1,437,635 shares, which was above its three months average volume of 1,375,291 shares. In the last year, Teladoc Health's shares have traded in a range of 27.30 - 79.64. The share price has gained 186.08% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $74.38 is above its 200-day moving average of $56.98. Shares of Teladoc Health have fallen roughly 0.53 percent in the past month and are up 116.36 percent year-to-date.

Access RDI's Teladoc Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TDOC

On Friday, shares of CV Sciences recorded a trading volume of 2,229,272 shares, which was below the three months average volume of 4,190,612 shares. The stock ended the day 5.39% lower at $5.09. The share price has fallen 44.67% from its 52 week high with a 52 week trading range of 0.14 - 9.20. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.79 is above its 200-day moving average of $2.13. Shares of the company are trading at a Price to Earnings ratio of 124.15. Shares of CV Sciences have fallen roughly 17.48 percent in the past month and are up 767.74 percent year-to-date.

Access RDI's CV Sciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CVSI

Our Actionable Research on Teladoc Health, Inc. (NYSE:TDOC) and CV Sciences, Inc. (OTCQB:CVSI) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com